Stuart retires today 12 June 2020 as the Chief Executive of Oxford Health NHS Foundation Trust. He was a founder member of the Oxford AHSC and instrumental as a Board member in leading the recent designation process ensuring the importance of all aspects for mental health care and treatment, research and education and training. He […]
Oxford University has received a landmark £80 million donation from the Reuben Foundation that will transform Oxford’s newest college and establish a major new scholarship programme for graduate and undergraduate students. © Alison Stibbe The University last year established its 39th college – the first for 30 years – as a new base for graduate […]
As part of the UK NIHR multi-arm, multi-stage CATALYST Trial, researchers at the University of Oxford will investigate whether administering the anti-inflammatory drug infliximab to patients with COVID-19 can prevent progression to respiratory failure or death. In some patients, COVID-19 can progress to severe respiratory failure requiring admission to an intensive care unit and mechanical […]
A team of radiologists and radiographers at Oxford University Hospitals and University of Oxford’s Department of Oncology has secured a grant to customise a teaching platform to educate frontline NHS staff to diagnose COVID-19 using chest X-rays and CT scans. Dr Sarim Ather, a Specialist Registrar in Clinical Radiology, has been working alongside Professor Fergus Gleeson (Department […]
On 2 June, the Brazilian Health Regulatory Agency (ANVISA) approved the inclusion of Brazil in the clinical trials conducted by Oxford University and supported by AstraZeneca, considering 2,000 volunteers to be tested in the country. On April 30, the University of Oxford and AstraZeneca announced an agreement for the global development and distribution of the […]
The University of Oxford in partnership with AstraZeneca has taken the next steps in its commitment to broad and equitable global access to Oxford’s COVID-19 vaccine, following landmark agreements with the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi the Vaccine Alliance, and the Serum Institute of India (SII). AstraZeneca has reached a $750m agreement with […]
Researchers at the University of Oxford are working with clinical collaborators from NHS hospitals to carry out a new clinical drug trial aimed at treating COVID-19, funded by LifeArc. It will test a drug that could raise oxygen levels in the blood in COVID-19 patients in order to improve their chances of recovery. Raising oxygen […]
Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort. The grant will be made available through the Westminster Foundation to support the University’s Department of Psychiatry, which […]
A Mental Health Urgent Care Centre has been launched in Buckinghamshire to support adults who need vital mental health care during the coronavirus outbreak. The urgent care centre, established at Peach Tree House in the grounds of Whiteleaf Mental Health Centre in Aylesbury, offers a round-the-clock alternative to A&E for people who require immediate in-person care […]
University of Oxford researchers have begun recruiting for the next phase in human trials of a COVID-19 vaccine in human volunteers. The phase I trial in healthy adult volunteers began in April. More than 1,000 immunisations have been completed and follow-up is currently ongoing. The next study will enrol up to 10,260 adults and children and will […]